HCA Healthcare (HCA) Scheduled to Post Quarterly Earnings on Friday

HCA Healthcare (NYSE:HCA) will be posting its quarterly earnings results before the market opens on Friday, October 25th. Analysts expect HCA Healthcare to post earnings of $4.93 per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. The business had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company’s revenue was up 10.3% compared to the same quarter last year. During the same period last year, the company posted $4.29 EPS. On average, analysts expect HCA Healthcare to post $23 EPS for the current fiscal year and $25 EPS for the next fiscal year.

HCA Healthcare Stock Performance

HCA opened at $410.03 on Thursday. The firm has a market cap of $107.39 billion, a PE ratio of 20.44, a P/E/G ratio of 1.44 and a beta of 1.67. The business has a fifty day simple moving average of $394.72 and a 200-day simple moving average of $352.30. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare has a fifty-two week low of $215.96 and a fifty-two week high of $417.14.

Analyst Ratings Changes

Several analysts have recently commented on the company. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Royal Bank of Canada raised their target price on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Wells Fargo & Company increased their price objective on HCA Healthcare from $365.00 to $395.00 and gave the stock an “equal weight” rating in a report on Tuesday. UBS Group increased their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Finally, Truist Financial increased their price objective on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Five analysts have rated the stock with a hold rating, fourteen have issued a buy rating and four have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $367.15.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the transaction, the senior vice president now owns 9,454 shares of the company’s stock, valued at $3,436,623.54. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,345 shares of company stock valued at $5,747,945. 1.60% of the stock is currently owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.